» Articles » PMID: 2566725

Myeloproliferative Disorders: Usefulness of X-linked Probes in Diagnosis

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 1989 Jun 1
PMID 2566725
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Myeloproliferative disorders are neoplasms of the pluripotent hematopoietic stem cell. Accurate diagnosis and distinction from reactive processes can be difficult therein with cytogenetic analysis only being useful in a minority of patients. Use of X-linked restriction fragment length polymorphism and methylation analysis has enabled clonal analysis to be performed in up to 50% of females, significantly increasing the proportion of analyzable patients over methods dependent on glucose-6-phosphate dehydrogenase heterozygosity. Using hypoxanthine phosphoribosyl transferase and phosphoglycerate kinase probes, we have demonstrated monoclonality of peripheral blood leukocytes in three females with myeloproliferative disorders who had uninformative chromosomal analysis. This technique greatly enhances the diagnosis of early myeloproliferative disorder.

Citing Articles

Myeloproliferative Neoplasms: Challenging Dogma.

Spivak J J Clin Med. 2024; 13(22).

PMID: 39598101 PMC: 11595126. DOI: 10.3390/jcm13226957.


Polycythemia Vera.

Spivak J Curr Treat Options Oncol. 2018; 19(2):12.

PMID: 29516275 DOI: 10.1007/s11864-018-0529-x.


A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera.

Sacchi S, Leoni P, Liberati M, Riccardi A, Tabilio A, Tartoni P Ann Hematol. 1994; 68(5):247-50.

PMID: 8018766 DOI: 10.1007/BF01737425.


Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

Gilliland D, Blanchard K, Levy J, Perrin S, BUNN H Proc Natl Acad Sci U S A. 1991; 88(15):6848-52.

PMID: 1862109 PMC: 52186. DOI: 10.1073/pnas.88.15.6848.